Avalo

Durham, United States

Avalo is a plant biotech company using AI and evolution to make a more sustainable and resilient food system.

$11.0M raised

Mar 2025

Series A

Top Investors

Giant VenturesSOSVBetter VenturesGermin8 VenturesAt One Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Avalo raised?

Avalo has raised $11.0M in total funding. The most recent round was Series A. The last funding was announced in March 2025.

Who are Avalo's investors?

Avalo's investors include Giant Ventures, SOSV, Better Ventures, Germin8 Ventures, At One Ventures.

Where is Avalo headquartered?

Avalo is headquartered in Durham, United States.

What does Avalo do?

Avalo is a plant biotech company using AI and evolution to make a more sustainable and resilient food system.

What stage is Avalo at?

Avalo is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 6, 2025.

MLA

"Avalo — Funding & Investors." VCBacked, March 6, 2025, https://www.vcbacked.co/company/avalo. Accessed June 4, 2026.

APA

VCBacked. (2025). Avalo — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/avalo

Wikipedia (cite web)

{{cite web |title=Avalo — Funding & Investors |url=https://www.vcbacked.co/company/avalo |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 6, 2025.